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Maximilian Muenke2,*As a member of the awards committee of the American
Society of Human Genetics, it is my privilege, great honor,
and pleasure to introduce to you the winner of the 2011
William Allan Award: Dr. John M. Opitz.
Dr. Opitz is unarguably a pioneer in the field of medical
genetics. The year 2012 will mark 50 years of working in
this field to which he has contributed over 500 publica-
tions in peer-reviewed journals. Dr. Opitz is a rare scholar
and polyglot who speaks several languages in addition to
his native German. He has used this knowledge to read
texts in their original language and include pertinent
references and ideas into his writings on embryology, fetal
pathology, developmental biology, and medical genetics.
Dr. Opitz is probably best known for working with
patients and their families in order to observe and delin-
eate many of the now classical genetic syndromes. He
very well might be the single one geneticist who has
described the most novel syndromes. In order to honor
the patients rather than to call attention to the identifying
clinician, Dr. Opitz named these syndromes after the first
initials of the families that they affected, such as G syn-
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them now bear his name as in Smith-Lemli-Opitz
syndrome6 and Opitz syndrome (for GBBB syndrome).
Not only did Dr. Opitz delineate novel syndromes in the
1960s, 70s, and 80s, but he also helped to understand
the constellation of findings in the context of normal
and abnormal embryological development. It was Dr.
Opitz who rediscovered the concept of developmental field
defect in humans,7,8 a concept that was previously
described in amphibians by the German Nobel Laureate
Hans Spemann. Over the past two decades, Dr. Opitz has
been actively involved in the identification of the under-
lying genetic bases of the various syndromes that he had
previously described.9–11 The disease-associated genes of
two of these syndromes, Bohring-Opitz syndrome
(ASXL1)12 and KBG syndrome (ANKRD11),13 were recently
described.
Dr. Opitz was the founding editor and, for 25 years, the
editor-in-chief of the American Journal of Medical
Genetics (1976–2001). Not only did he create a forum to
exchange ideas between clinicians and basic scientists,
but he was also a mentor to a generation of geneticists.
Allow me to indulge in two brief personal examples. My
interactions with Dr. Opitz began in 1987 when, as a
clinical-genetics fellow at the Children’s Hospital of
Philadelphia, I had submitted my first manuscript on
patients with holoprosencephaly.14 Along with the
reviewers’ comments, I also received Dr. Opitz’s feedback. I
was reminded of the children’s riddle, ‘‘What is black and
white and re(a)d all over?’’ In the US, every parent of a
5–8-year-old child knows, of course, that the answer is ‘‘a
newspaper.’’ After Dr. Opitz’s edits with his famous
‘‘red pen,’’ the answer to ‘‘What is black and white and
re(a)dall over?’’was then ‘‘Amanuscript editedbyDr.Opitz.’’
Another form ofmentoring camewhenDr. Opitz invited
me to review several manuscripts on the topic of holopro-
sencephaly. When I was still in clinical-genetics training,
he asked me to also write a review article to accompany
the other holoprosencephaly manuscripts.15 This was the
push that I needed to start investigating the underlying
causes of normal and abnormal brain development. And
that is what my lab has focused on for the past two
decades. So, it is no exaggeration to state that my career
was shaped and defined by Dr. Opitz’s earlyternational Congress of Human Genetics on October 13, 2011 in Montreal,
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encouragement. I know of several other colleagues who
had a similar career boost from Dr. Opitz.
In closing, let me tell you about Dr. Opitz’s love of nature
and, most of all, his dedication to his patients and their
families. I have witnessed this personally at a weekend
with a support group for parents who had children with
various intellectual and/or physical disabilities. His
warmth, caring, and compassion had a healing effect on
the families even when little else could be offered from
the medical field.
Join me in celebrating a giant in the field of medical
genetics, Dr. John Opitz, the winner of the 2011 William
Allan Award!References
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